Abstract:Background Glutaraldehyde (GA) is the common fixative agent for bioprosthetic heart valves (BHVs). However, its chemical instability can expose calcium binding sites and, at commercially used concentrations, GA does not ensure effective immunological tolerance, triggering an immune response correlated to degeneration. Recently, polyphenols (PPs) achieved an almost complete xenoantigens inactivation in GA-fixed BHVs ensuring chemical stability of the treated tissue while improving mechanical characteristics and adding anti-infective and anti-thrombotic properties [1-4]. Purpose A new PP-based treatment has been introduced as a potential GA substitute in BHV manufacturing. The unique chemical properties of PPs permit them to interact with the tissue through stable chemical bonds without depolymerization over time, achieving several improvements that promise to extend the long-term durability of BHVs (Fig.1). Methods The study compared the effects of two cross-linking methods on bovine pericardial tissue: (1) traditional fixation in GA, and (2) treatment with PPs without GA. The type of chemical interaction between PPs and tissue was evaluated through nuclear magnetic resonance. The xenoantigens inactivation was quantified in-vitro by ELISA test and in-vivo in a humanized mouse animal model. Biomechanical properties were assessed through uniaxial stress-strain tests and cross-link density through the shrinkage temperature test. The protective effect against bacterial adhesion was evaluated against a strain of S aureus, while the inhibition of thrombosis was evaluated in-vivo in a pig animal model and in-vitro in a blood-loop using bovine blood with radio-labeled platelets. Results PPs effectuated multiple chemical bonds with and within the pericardium including cross-links based on covalent and hydrogen bonds, stacking, and electrostatic interactions. The inactivation of over 90% of surface-xenoantigens of the treated tissue allowed for superior biocompatibility (compared to <50% by commercial GA concentrations). The increase in elongation exhibited by PP-treated tissue confirmed excellent biomechanical features (Fig.2) while a sufficient degree of cross-linking was demonstrated through an adequate shrinkage temperature. Furthermore, a significant degree of bacterial adhesion (86% inhibition evaluated with S. aureus) and thrombus formation (Fig.2, up to 90% inhibition) were observed. Conclusion There is a real clinical need for improved chemical stability, calcification resistance, and immunological tolerance of current BHVs (surgical and transcatheter). PP technology may substitute the use of GA extending their performance and durability, thereby opening trans-catheter heart valves to younger patients. Reducing the need for mechanical heart valves would also address the associated risks of lifelong anticoagulation therapy.Figure 1Figure 2

Improved endothelial viability of heart valves cryopreserved by a new technique

Experimental Study on Cryopreserved Aortic Homograft Interposed in the Inferior Vena Cava in Canine

Bioprosthetic Heart Valves with Reduced Immunogenic Residuals Using Vacuum-Assisted Decellularization Treatment.

Effects of different cryoprotectants and cooling methods on the histology and immunogenicity of heart valves

Study on the Function of the Cryopreserved Vascular Endothelium

Prevention of Bioprosthetic Heart Valve Calcification: Strategies and Outcomes.

Protective Effect of Chondroitin Sulfate on Homograft Aortic Valve Cryopreserved in Liquid Nitrogen

The Structural and Cellular Viability in Cryopreserved Rabbit Carotid Arteries.

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

The Influence of the Cooling-Rate to the Effect of the Porcine Aortic Cryopreservation

Impact of cryopreservation on elastomuscular artery mechanics

Basic Function Testing of Cryopreserved Arteries

A Quick and Effective Modification Method to Improve the Patency and Endothelialization of Cryopreserved Allogenic Blood Vessels

Experimental Study on Acellular Heart Valves and Vessels by Ultrahigh Pressure Treatment

Cellular electrophysiologic and mechanical evidence of superior vascular protection in pulmonary microcirculation by Perfadex compared with Celsior

Effect of pre-freezing rate on porosity ratio and mechanical property of pig aorta.

Tissue-engineered blood vessel scaffolds with valves prepared by hyperpressure acellular technique

Tissue Engineering of Heart Valves: Endothelial Cells Differentiated from Endothelial Progenitor Cells Seeding of Acellularized Porcine Valves

Dynamic glutaraldehyde fixation of a porcine aortic valve xenograft. I. Effect of fixation conditions on the final tissue viscoelastic properties

Polyphenol-treatment without preceding glutaraldehyde fixation: a potential paradigm change for bioprosthetic heart valves

Comparative Study of the Triton X-100-sodium Deoxycholate Method and Detergent-Enzymatic Digestion Method for Decellularization of Porcine Aortic Valves.